Skip to main content

Table 1 Treatment assignment based on core CGA testing

From: A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)

 

GO-GO arm

SLOW-GO arm

FRAIL arm

ECOG

0–1

≤ 2

≥ 3

G8-Questionaire

>  14 points

≤ 14 points

<  14 points

ADL (Barthel)

= 100

≤ 100

<  100

IADL

= 8 (f) / = 5 (m)

≤ 8 (f) / ≤ 5 (m)

<  8 (f) / < 5 (m)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us